When is non‑small cell lung carcinoma considered resectable versus non‑resectable?

Resectability Determination in NSCLC

NSCLC is considered resectable when a multidisciplinary team determines that complete R0 resection is technically achievable with acceptable operative risk, primarily based on the extent of mediastinal nodal involvement rather than T stage alone. 1, 2

Key Radiographic Categories for Resectability Assessment

The American College of Chest Physicians defines two critical patterns that guide resectability 1:

Infiltrative (Bulky) N2/N3 Disease = UNRESECTABLE

• Multiple mediastinal nodes matted together with obscured boundaries
• Nodes encircling major structures (great vessels, trachea)
• Cannot distinguish individual nodes on imaging
• Invasive staging typically not required as imaging alone suffices
• Treatment approach: Definitive concurrent chemoradiotherapy 1, 2

Discrete N2/N3 Disease = POTENTIALLY RESECTABLE

• Individual mediastinal nodes can be distinguished and measured
• May be enlarged or normal-sized
• Often show PET uptake
• Requires mandatory invasive staging confirmation via EBUS/EUS or mediastinoscopy 2

Specific Nodal Status Criteria

Resectable scenarios:

• N0-N1 disease (any T stage except unresectable T4)
• Single-station N2 disease with discrete, non-bulky nodes 2, 3
• T3-T4 tumors based on size/satellite nodules with N0-N1 3

Unresectable scenarios:

• Multi-station N2 disease (95-100% consensus unresectable) 3
• Bulky N2 disease (95% consensus unresectable) 3
• N3 disease (95% consensus unresectable) 3
• T4 tumors with mediastinal nodal involvement 4

Critical Staging Requirements

Before declaring resectability 4, 2:

1. Extrathoracic imaging mandatory for T4 N0-1 tumors (brain MRI/CT + PET or abdominal CT + bone scan)
2. Invasive mediastinal staging required for:
   • Central tumors (even without enlarged nodes on imaging)
   • Hilar lymph node involvement
   • Any discrete mediastinal nodes on CT/PET 2
3. Negative EBUS/EUS requires confirmatory mediastinoscopy if nodes remain suspicious 2

Important Caveats

The term "potentially resectable" is deliberately avoided in modern guidelines because it is subjective, surgeon-dependent, and inaccurate—25-35% of patients judged "resectable" ultimately undergo incomplete (R1/R2) resection 1. Instead, objective radiographic categorization is preferred.

Performance status and comorbidities must support tolerance of both surgery and multimodality therapy, not just the operation itself 1.

Specialized center referral is mandatory for T4 N0-1 tumors being considered for resection given complexity and high operative mortality 4.

Algorithmic Approach

1. Obtain high-quality CT and PET imaging
2. If infiltrative/bulky mediastinal disease → unresectable → concurrent chemoradiotherapy
3. If discrete nodes present → invasive staging mandatory
   • If multi-station N2, bulky N2, or N3 confirmed → unresectable
   • If single-station N2 confirmed → potentially resectable, requires MDT discussion
4. If no mediastinal nodes but central tumor/hilar nodes → invasive staging required
5. If peripheral tumor, no nodes → proceed to surgery without invasive staging 2

For stage IIIA disease with discrete single-station N2, both definitive chemoradiotherapy and neoadjuvant therapy followed by surgery are acceptable options 2, with surgery preferred only when lobectomy (not pneumonectomy) is feasible at experienced centers with low perioperative mortality 1.